Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Effect of immunosuppression in miRNAs from extracellular vesicles of colorectal cancer and their influence on the pre-metastatic niche.

Tubita V, Segui-Barber J, Lozano JJ, Banon-Maneus E, Rovira J, Cucchiari D, Moya-Rull D, Oppenheimer F, Del Portillo H, Campistol JM, Diekmann F, Ramirez-Bajo MJ, Revuelta I.

Sci Rep. 2019 Aug 1;9(1):11177. doi: 10.1038/s41598-019-47581-y.

2.

Tofacitinib Halts Progression of Graft Dysfunction in a Rat Model of Mixed Cellular and Humoral Rejection.

Rovira J, Ramírez-Bajo MJ, Banon-Maneus E, Lazo-Rodríguez M, Moya-Rull D, Hierro-Garcia N, Tubita V, Piñeiro GJ, Revuelta I, Ventura-Aguiar P, Cucchiari D, Oppenheimer F, Brunet M, Campistol JM, Diekmann F.

Transplantation. 2018 Jul;102(7):1075-1084. doi: 10.1097/TP.0000000000002204.

PMID:
29620612
3.

Inhibition of JAK3 and PKC via Immunosuppressive Drugs Tofacitinib and Sotrastaurin Inhibits Proliferation of Human B Lymphocytes In Vitro.

Martina MN, Ramirez Bajo MJ, Bañon-Maneus E, Moya Rull D, Hierro-Garcia N, Revuelta I, Campistol JM, Rovira J, Diekmann F.

Transplant Proc. 2016 Nov;48(9):3046-3052. doi: 10.1016/j.transproceed.2016.07.052.

PMID:
27932144
4.

mTOR Inhibition: Reduced Insulin Secretion and Sensitivity in a Rat Model of Metabolic Syndrome.

Rovira J, Ramírez-Bajo MJ, Banon-Maneus E, Moya-Rull D, Ventura-Aguiar P, Hierro-Garcia N, Lazo-Rodriguez M, Revuelta I, Torres A, Oppenheimer F, Campistol JM, Diekmann F.

Transplant Direct. 2016 Jan 22;2(2):e65. doi: 10.1097/TXD.0000000000000576. eCollection 2016 Feb.

5.

Wnt pathway activation in long term remnant rat model.

Banon-Maneus E, Rovira J, Ramirez-Bajo MJ, Moya-Rull D, Hierro-Garcia N, Takenaka S, Diekmann F, Eickelberg O, Königshoff M, Campistol JM.

Biomed Res Int. 2014;2014:324713. doi: 10.1155/2014/324713. Epub 2014 Jun 5.

6.

Sirolimus-associated testicular toxicity: detrimental but reversible.

Rovira J, Diekmann F, Ramírez-Bajo MJ, Bañón-Maneus E, Moya-Rull D, Campistol JM.

Transplantation. 2012 May 15;93(9):874-9. doi: 10.1097/TP.0b013e31824bf1f0.

PMID:
22357177
7.

Enzymatic and metabolic characterization of the phosphoglycerate kinase deficiency associated with chronic hemolytic anemia caused by the PGK-Barcelona mutation.

Ramírez-Bajo MJ, Repiso A, la Ossa PP, Bañón-Maneus E, de Atauri P, Climent F, Corrons JL, Cascante M, Carreras J.

Blood Cells Mol Dis. 2011 Mar 15;46(3):206-11. doi: 10.1016/j.bcmd.2010.12.009. Epub 2011 Jan 26.

PMID:
21269848
8.

Two-dimensional difference gel electrophoresis urinary proteomic profile in the search of nonimmune chronic allograft dysfunction biomarkers.

Bañón-Maneus E, Diekmann F, Carrascal M, Quintana LF, Moya-Rull D, Bescós M, Ramírez-Bajo MJ, Rovira J, Gutierrez-Dalmau A, Solé-González A, Abián J, Campistol JM.

Transplantation. 2010 Mar 15;89(5):548-58. doi: 10.1097/TP.0b013e3181c690e3.

PMID:
20134395
9.

Urine proteomics biomarkers in renal transplantation: an overview.

Quintana LF, Bañon-Maneus E, Solé-Gonzalez A, Campistol JM.

Transplantation. 2009 Aug 15;88(3 Suppl):S45-9. doi: 10.1097/TP.0b013e3181af7cba. Review.

PMID:
19667961
10.

Mammalian target of rapamycin inhibition prevents glomerular hypertrophy in a model of renal mass reduction.

Rovira J, Arellano EM, Carreras J, Campos B, Vodenik B, Bañón-Maneus E, Ramírez-Bajo MJ, Moya-Rull D, Solé-González A, Hernández A, Revuelta I, Quintana LF, Howat WJ, Campistol JM, Diekmann F.

Transplantation. 2009 Sep 15;88(5):646-52. doi: 10.1097/TP.0b013e3181b24463.

PMID:
19741461
11.

Application of label-free quantitative peptidomics for the identification of urinary biomarkers of kidney chronic allograft dysfunction.

Quintana LF, Campistol JM, Alcolea MP, Bañon-Maneus E, Sol-González A, Cutillas PR.

Mol Cell Proteomics. 2009 Jul;8(7):1658-73. doi: 10.1074/mcp.M900059-MCP200. Epub 2009 Apr 7.

12.

Urine proteomics to detect biomarkers for chronic allograft dysfunction.

Quintana LF, Solé-Gonzalez A, Kalko SG, Bañon-Maneus E, Solé M, Diekmann F, Gutierrez-Dalmau A, Abian J, Campistol JM.

J Am Soc Nephrol. 2009 Feb;20(2):428-35. doi: 10.1681/ASN.2007101137. Epub 2008 Dec 3.

13.

Effect of mTOR inhibitor on body weight: from an experimental rat model to human transplant patients.

Rovira J, Marcelo Arellano E, Burke JT, Brault Y, Moya-Rull D, Bañón-Maneus E, Ramírez-Bajo MJ, Gutiérrez-Dalmau A, Revuelta I, Quintana LF, Campistol JM, Diekmann F.

Transpl Int. 2008 Oct;21(10):992-8. doi: 10.1111/j.1432-2277.2008.00710.x. Epub 2008 Jul 24.

14.

Mammalian target of rapamycin inhibition halts the progression of proteinuria in a rat model of reduced renal mass.

Diekmann F, Rovira J, Carreras J, Arellano EM, Bañón-Maneus E, Ramírez-Bajo MJ, Gutiérrez-Dalmau A, Brunet M, Campistol JM.

J Am Soc Nephrol. 2007 Oct;18(10):2653-60. Epub 2007 Sep 5.

15.

Increased serum creatine kinase is a reliable marker for acute transplanted heart rejection diagnosis in rats.

Bañón-Maneus E, Kahbiri E, Marín JL, Pomar-Moya JL, Ramírez J, Climent F, de la Ossa PP.

Transpl Int. 2007 Feb;20(2):184-9.

Supplemental Content

Loading ...
Support Center